Inflammatory Disease Clinical Trials

41 recruitingLast updated: June 18, 2026

There are 41 actively recruiting inflammatory disease clinical trials across 30 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Paris, France, Bethesda, Maryland, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Inflammatory Disease Trials at a Glance

41 actively recruiting trials for inflammatory disease are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Paris, Bethesda, and Beijing. Lead sponsors running inflammatory disease studies include Peking Union Medical College Hospital, Assistance Publique - Hôpitaux de Paris, and Hospices Civils de Lyon.

Browse inflammatory disease trials by phase

Treatments under study

About Inflammatory Disease Clinical Trials

Looking for clinical trials for Inflammatory Disease? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

ObesityCardiomyopathyLi-Fraumeni Syndrome+3 more
National Heart, Lung, and Blood Institute (NHLBI)5,000 enrolled3 locationsNCT01143454
Recruiting

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

Autoinflammatory DiseaseJuvenile Dermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)5,000 enrolled1 locationNCT00059748
Recruiting
Phase 1

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

Multiple SclerosisProgressive Multifocal LeukoencephalopathyOther Neuroinflammatory Diseases With BBB Leakage
National Institute of Neurological Disorders and Stroke (NINDS)15 enrolled1 locationNCT05849467
Recruiting

A Repository to Study Host-Microbiome Interactions in Health and Disease

PregnancyHealthy (Controls)Pediatric Illnesses+1 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT05656378
Recruiting

Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy

Inflammatory DiseaseRetinal DiseaseOcular Surface Disease+1 more
Dan Chen3,000 enrolled1 locationNCT07628946
Recruiting

Diagnosis, Determining Factors, and Characteristics of Pathologies Associated With Autoinflammatory Diseases.

Rare Autoinflammatory Disease
Hospices Civils de Lyon50 enrolled1 locationNCT07622069
Recruiting
Not Applicable

Deployment o the Multidisciplinary Prospective Cohort Imminent

Severe AsthmaMultiple SclerosisAtopic Dermatitis+6 more
University Hospital, Lille2,200 enrolled1 locationNCT04334031
Recruiting
Phase 2

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

MicrobiomeHIVCannabis+3 more
University of California, San Diego90 enrolled1 locationNCT05514899
Recruiting
Not Applicable

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Cervical CarcinomaEndometrial CarcinomaEndometriosis+1 more
Mayo Clinic120 enrolled3 locationsNCT04567771
Recruiting

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

AsthmaVasculitisInflammatory Disease+2 more
Imperial College London120 enrolled1 locationNCT05012033
Recruiting

Molecular Diagnosis of Systemic Autoinflammatory Diseases

Genetic DiseaseMolecular Pathway DeregulationSomatic Mutation+2 more
Institut National de la Santé Et de la Recherche Médicale, France300 enrolled1 locationNCT05364294
Recruiting
Not Applicable

68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases

Inflammatory Disease
University Hospital, Brest390 enrolled1 locationNCT06275477
Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Inflammatory Bowel DiseasesHeart DiseasesAutoimmune Disease+5 more
University of Chicago1,200 enrolled1 locationNCT01280825
Recruiting

UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study

Cardiovascular DiseasesImmune-Mediated Inflammatory Diseases
University of Manchester600 enrolled2 locationsNCT06478277
Recruiting

Genetic Variants and Regulation of Specialized Pro-resolving Mediator

Cardiovascular DiseasesHealthyInflammatory Disease
Queen Mary University of London200 enrolled1 locationNCT04698291
Recruiting
Not Applicable

Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases

Genetic DiseaseAutoimmune DiseasesAutoinflammatory Disease+1 more
Hospices Civils de Lyon400 enrolled13 locationsNCT06435468
Recruiting
Phase 2

Personalized Therapies in Inflammatory Complex Disease

Autoimmune DiseasesInflammatory Disease
Assistance Publique - Hôpitaux de Paris32 enrolled1 locationNCT03651518
Recruiting

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital120 enrolled1 locationNCT06845410
Recruiting

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital39 enrolled1 locationNCT05860400
Recruiting

Disease Characteristics of IR-CAD: a Case-control Study

Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital30 enrolled1 locationNCT06007248